Psychopathology
depressive
Although high and low frequency treatments will both produce clinical improvement, improvement will be significantly greater for high frequency treatment in structural integration (measured with the Operationalized Psychodynamic Diagnosis Structure Questionnaire (OPD-SQ)), depressive symptoms (measured with the BDI-2), and in the manifest dreams (measured with DREams Assessment Scale for measuring Changes in manifest dream (DREAMS-C). Improvement in these clinical measures will associate significantly with the regional changes in MRI measures that change in response to high vs low frequency treatment.